CVS, Walgreens Say They Will Offer Abortion Pills in Some States
FRIDAY, Jan. 6, 2023 (HealthDay News) — Two major pharmacy chains, CVS and Walgreens, plan to offer abortion pills in states that do not have restrictions that would prevent dispensing the medications. This likely will not increase access in states t…
Learn MoreVV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19
FRIDAY, Jan. 6, 2023 (HealthDay News) — VV116 is noninferior to nirmatrelvir-ritonavir with respect to time to sustained clinical recovery for adults with mild-to-moderate COVID-19 at risk for progression, according to a study published online Dec. 2…
Learn MoreModified Atkins Diet Plus Drug Therapy Beneficial in Drug-Resistant Epilepsy
THURSDAY, Jan. 5, 2023 (HealthDay News) — For adults and adolescents with drug-resistant epilepsy (DRE), the addition of the modified Atkins diet (MAD) to standard drug therapy (SDT) is more effective for reducing seizure frequency and improving qual…
Learn MoreFDA Says Retail Pharmacies Can Now Offer Abortion Pills
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — The U.S. Food and Drug Administration finalized a regulatory change on Tuesday that allows retail pharmacies to offer abortion pills. Before now, patients could only get this two-drug medication through clin…
Learn MoreAntiepileptic Drugs Tied to Incident Parkinson Disease
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Antiepileptic drugs are associated with incident Parkinson disease, according to a study published online Dec. 27 in JAMA Neurology.Daniel Belete, M.B.Ch.B., from Queen Mary University of London, and colleag…
Learn MoreBiomarkers Elevated in Patients With Immune Checkpoint Inhibitor-Induced Myocarditis
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — Immune checkpoint inhibitor (ICI) myocarditis is associated with changes in noncardiac biomarkers, with elevated creatine phosphokinase (CPK) associated with myocarditis development and all-cause mortality, …
Learn MoreDAAs Less Likely for Hep C Patients With Alcohol Use Disorder
WEDNESDAY, Jan. 4, 2023 (HealthDay News) — For patients with hepatitis C virus (HCV), those with current alcohol use disorder (AUD) or a history of AUD are less likely to receive direct-acting antiviral (DAA) treatment, according to a study published…
Learn MoreDrug Approved to Help Young Patients Battle a Rare Cancer
TUESDAY, Jan. 3, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved the immunotherapy drug Tecentriq (atezolizumab) for use in patients with unresectable or metastatic alveolar soft part sarcoma (ASPS). The approval was grante…
Learn MoreUna nueva pastilla para la COVID podría ser mejor que Paxlovid, sugiere un ensayo chino
VIERNES, 30 de diciembre de 2022 (HealthDay News) — Los pacientes con COVID-19 quizá pronto tengan una nueva pastilla antiviral que los proteja de una enfermedad grave.El tratamiento, llamado VV116, funcionó igual que bien que Paxlovid en las persona…
Learn MoreAdverse Events Increased for Induced Abortion With Mifepristone-Misoprostol
TUESDAY, Jan. 3, 2023 (HealthDay News) — For women undergoing first-trimester induced abortion (IA), short-term adverse events are more likely among those prescribed mifepristone-misoprostol than procedural IA, according to a study published online J…
Learn More